The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.
The aim of this study is to investigate oral administration of L. rhamnosus GG (LGG) in early life on the growth performance, diarrhea, intestinal health, and microbiota of post-weaning piglets. Ninety-six newborn piglets were randomly divided into two groups. Piglets were orally administered with 2 mL of 10% sterile skim milk or 2 mL of 10% sterile skim milk suspended with viable LGG (1 × 108 CFU/mL). Results showed that compared with the control group, oral administration of LGG in early life slightly decreased diarrhea incidence. Furthermore, LGG supplementation maintained the intestinal barrier integrity (HE, DAO) and reduced the generation of the inflammatory response. 16S rRNA sequencing showed that LGG modulated the colon microbiota composition of piglets by increasing the relative abundance of Bifidobacterium, Helicobacter, Mucispirillum, and Dorea. Metabolomic study suggested that LGG substantially influenced the intestinal metabolic profile, particularly compounds associated with the biosynthesis of unsaturated fatty acids. The metabolic alterations were closely linked to the enhancement of the microbial community makeup. The analysis of jejunum RNA sequencing indicated that, in comparison to the CON group, LGG significantly downregulated various immune-related signaling pathways, especially the PI3K/AKT pathways. Correlation analysis of microbiota, metabolism, and genes uncovered a substantial association between the taxa enhanced by LGG and the critical genes in the PI3K/AKT signaling pathways. The coculture system of LGG and intestinal organoids revealed that LGG alleviated TNF-α induced injury through inhibiting the PI3K/AKT signaling pathway. Overall, the integrated analysis of multiple omics approaches revealed that LGG reduced post-weaning induced intestinal injury through the regulation of gut microbiota, modification of metabolic profiles, reinforcement of the intestinal barrier, and downregulation of the PI3K/AKT signaling pathway.
Serum chloride is routinely available in critical care, but its prognostic association with pulmonary embolism (PE) has not been well characterized using m
Rhabdomyolysis is classically understood as skeletal muscle injury complicated by myoglobin-mediated acute kidney injury, but this framework does not fully explain the diagnostic and clinical complexity created by liver disease, aminotransferase abnormalities, and multiorgan dysfunction. This narrative review summarizes clinical and experimental evidence on liver, muscle, and kidney interactions in rhabdomyolysis. Relevant studies addressing aminotransferase elevation, liver-related susceptibility to muscle injury, rhabdomyolysis-associated kidney injury, interorgan communication, and shared systemic insults were reviewed. The evidence indicates that aminotransferase elevation in rhabdomyolysis often reflects muscle injury rather than primary hepatic damage, requiring interpretation with serial enzyme trends, liver-specific markers, and clinical context. Liver disease may increase vulnerability to muscle injury and kidney injury through sarcopenia, metabolic disturbance, altered drug handling, and impaired perfusion. Severe rhabdomyolysis may also contribute to hepatic stress through inflammation, heme-related pathways, and AKI-mediated effects, although direct causal evidence remains limited. A liver–muscle–kidney framework may improve integrated assessment, but prospective studies are needed to clarify temporal relationships and validate clinically useful biomarkers.